Tetrakis(5-tert-butyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)-1-methylpyrazole);2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);tris(iridium(3+));bis(5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide)
C119H115F18Ir3N24O4 — CID 157313447
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tetrakis(5-tert-butyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)-1-methylpyrazole);2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);tris(iridium(3+));bis(5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide)
Tetrakis(5-tert-butyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)-1-methylpyrazole);2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);tris(iridium(3+));bis(5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide) (PubChem CID 157313447) has the molecular formula C119H115F18Ir3N24O4 and a molecular weight of 2864.01 g/mol. Its IUPAC name is tetrakis(5-tert-butyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)-1-methylpyrazole);2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);tris(iridium(3+));bis(5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide).
Molecular Properties
| Compound Name | Tetrakis(5-tert-butyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)-1-methylpyrazole);2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);tris(iridium(3+));bis(5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide) |
|---|---|
| PubChem CID | 157313447 |
| Molecular Formula | C119H115F18Ir3N24O4 |
| Molecular Weight | 2864.01 g/mol |
| Exact Mass | 2864.81 |
| IUPAC Name | tetrakis(5-tert-butyl-3-(2-ethoxy-4-fluorobenzene-6-id-1-yl)-1-methylpyrazole);2-(1,2-diaza-3-azanidacyclopenta-1,4-dien-4-yl)pyridine;bis(3-(4-fluorobenzene-6-id-1-yl)-1-methyl-5-(trifluoromethyl)pyrazole);tris(iridium(3+));bis(5-(1-phenylimidazol-2-yl)-3-(trifluoromethyl)pyrazol-1-ide) |
| SMILES | CCOc1cc(F)c[c-]c1-c1cc(C(C)(C)C)n(C)n1.CCOc1cc(F)c[c-]c1-c1cc(C(C)(C)C)n(C)n1.CCOc1cc(F)c[c-]c1-c1cc(C(C)(C)C)n(C)n1.CCOc1cc(F)c[c-]c1-c1cc(C(C)(C)C)n(C)n1.Cn1nc(-c2[c-]cc(F)cc2)cc1C(F)(F)F.Cn1nc(-c2[c-]cc(F)cc2)cc1C(F)(F)F.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.FC(F)(F)c1cc(-c2nccn2-c2ccccc2)[n-]n1.[Ir+3].[Ir+3].[Ir+3].c1ccc(-c2cnn[n-]2)nc1 |
| InChI | InChI=1S/4C16H20FN2O.2C13H8F3N4.2C11H7F4N2.C7H5N4.3Ir/c4*1-6-20-14-9-11(17)7-8-12(14)13-10-15(16(2,3)4)19(5)18-13;2*14-13(15,16)11-8-10(18-19-11)12-17-6-7-20(12)9-4-2-1-3-5-9;2*1-17-10(11(13,14)15)6-9(16-17)7-2-4-8(12)5-3-7;1-2-4-8-6(3-1)7-5-9-11-10-7;;;/h4*7,9-10H,6H2,1-5H3;2*1-8H;2*2,4-6H,1H3;1-5H;;;/q9*-1;3*+3 |
| InChIKey | SUXQXFJROQIUQS-UHFFFAOYSA-N |
| XLogP | 27.29 |
| TPSA | 286.23 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 168 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2864.01 |
| LogP ≤ 5 | 27.29 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 25 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157313447 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.